Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5273352
Max Phase: Preclinical
Molecular Formula: C20H40N4O11
Molecular Weight: 512.56
Associated Items:
ID: ALA5273352
Max Phase: Preclinical
Molecular Formula: C20H40N4O11
Molecular Weight: 512.56
Associated Items:
Canonical SMILES: C[C@@H](O)[C@H]1O[C@H](O[C@H]2[C@H](O[C@@H]3O[C@H](CNCCO)[C@@H](O)[C@H]3O)[C@@H](O)[C@H](N)C[C@@H]2N)[C@H](N)[C@@H](O)[C@@H]1O
Standard InChI: InChI=1S/C20H40N4O11/c1-6(26)16-14(30)13(29)10(23)19(33-16)34-17-8(22)4-7(21)11(27)18(17)35-20-15(31)12(28)9(32-20)5-24-2-3-25/h6-20,24-31H,2-5,21-23H2,1H3/t6-,7-,8+,9-,10-,11+,12-,13-,14+,15-,16-,17-,18-,19-,20+/m1/s1
Standard InChI Key: HYIBBJNQVZQIKH-GBIAXBPOSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 512.56 | Molecular Weight (Monoisotopic): 512.2694 | AlogP: -6.64 | #Rotatable Bonds: 9 |
Polar Surface Area: 268.62 | Molecular Species: BASE | HBA: 15 | HBD: 11 |
#RO5 Violations: 3 | HBA (Lipinski): 15 | HBD (Lipinski): 14 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 12.17 | CX Basic pKa: 9.59 | CX LogP: -6.27 | CX LogD: -10.91 |
Aromatic Rings: 0 | Heavy Atoms: 35 | QED Weighted: 0.13 | Np Likeness Score: 1.46 |
1. Guchhait S, Khononov A, Pieńko T, Belakhov V, Baasov T.. (2023) Balancing Nonsense Mutation Readthrough and Toxicity of Designer Aminoglycosides for Treatment of Genetic Diseases., 14 (6): [PMID:37312846] [10.1021/acsmedchemlett.3c00089] |
Source(1):